Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver
- Most recent report
- 6-K, filed Aug 5, 2026
- Filings on record
- 239 filings
- On EDGAR
- CIK 1464165
- Fiscal year ends
- January
- Filer status
- Non-accelerated filer
Financials 8 of 156
- 6-K Report a foreign issuer made public elsewhere Aug 5, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 26, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 25, 2026
- 20-F Annual report, foreign issuer Jun 1, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 13, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 29, 2025
- 6-K Report a foreign issuer made public elsewhere Jul 28, 2025
- 6-K Report a foreign issuer made public elsewhere Jun 27, 2025
News 8 of 29
- 8-K Current report on a material event May 21, 2019
- 8-K Current report on a material event Feb 4, 2019
- 8-K Significant contract Dec 19, 2018
- 8-K Current report on a material event Nov 6, 2018
- 8-K Leadership change Sep 18, 2018
- 8-K/A Acquisition or disposal closed May 16, 2018
- 8-K Acquisition or disposal closed Mar 12, 2018
- 8-K Current report on a material event Dec 19, 2017
Prospectuses and Registrations 4
Proxies 8 of 9
- DEF 14A Proxy statement for a shareholder vote Feb 19, 2019
- DEF 14A Proxy statement for a shareholder vote Oct 27, 2017
- DEF 14A Proxy statement for a shareholder vote Nov 28, 2016
- DEF 14A Proxy statement for a shareholder vote Nov 25, 2015
- DEFR14A Aug 27, 2014
- DEFR14A Aug 20, 2014
- PRE 14A Preliminary proxy statement Aug 8, 2014
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2014
Ownership 6
- 5 Insider reported deferred transactions Mar 10, 2015
- 5 Insider reported deferred transactions Mar 10, 2015
- 3 Insider reported their initial holding Mar 10, 2015
- 3 Insider reported their initial holding Mar 3, 2015
- 3 Insider reported their initial holding Mar 3, 2015
- 3 Insider reported their initial holding Aug 6, 2010
Other 8 of 35
- 20-F/A Annual report, foreign issuer, amended Jun 6, 2023
- NT 20-F Jun 1, 2022
- 20-F/A Annual report, foreign issuer, amended Jun 23, 2021
- 20-F/A Annual report, foreign issuer, amended Jun 8, 2021
- 6-K/A Report a foreign issuer made public elsewhere, amended Aug 18, 2020
- 20-F/A Annual report, foreign issuer, amended Jun 5, 2020
- NT 20-F Jun 1, 2020
- NT 10-Q Notice that a quarterly report will be late Jun 17, 2019
Everything here comes from BetterLife Pharma Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.